Offspring mortality or severe neonatal morbidity · women at risk of preterm birth
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Neonatal death (death within the first 28 days of life) · women at risk of preterm birth
Strategies to increase use of antenatal corticosteroids probably leads to higher neonatal death before 28 days (at population level) compared with routine (usual) care (moderate certainty).
1 finding from 1 review
Appropriate ACS treatment (women) · women at risk of preterm birth
Strategies to increase use of antenatal corticosteroids may leads to higher appropriate ACS treatment (women) compared with routine (usual) care (low certainty).
1 finding from 1 review
Inappropriate ACS treatment (women) · women at risk of preterm birth
Strategies to increase use of antenatal corticosteroids may leads to higher inappropriate ACS treatment (women) compared with routine (usual) care (low certainty).
1 finding from 1 review
Maternal infection or inflammation (at population level) · women at risk of preterm birth
Strategies to increase use of antenatal corticosteroids may leads to higher maternal infection or inflammation (at population level) compared with routine (usual) care (low certainty).
1 finding from 1 review
Maternal death · women at risk of preterm birth
Strategies to increase use of antenatal corticosteroids showed no clear difference in maternal mortality (at population level) compared with routine (usual) care (low certainty).
1 finding from 1 review
Rate of weight gain (g/kg/day) · preterm or low birth weight infants
1 finding from 1 review
Linear growth (cm/week) · preterm or low birth weight infants
1 finding from 1 review
Growth velocity, head circumference, mm/d, end of intervention · preterm or low birth weight infants
1 finding from 1 review
Neurodevelopmental disability · preterm or low birth weight infants
Formula showed no clear difference in neurodevelopmental disability compared with donor breast milk (moderate certainty).
1 finding from 1 review
All‐cause mortality · preterm or low birth weight infants
Formula showed no clear difference in all‐cause mortality compared with donor breast milk (moderate certainty).
1 finding from 1 review
Necrotising enterocolitis · preterm or low birth weight infants
Formula probably leads to higher necrotising enterocolitis compared with donor breast milk (moderate certainty).
1 finding from 1 review
Episodes of abdominal distention > 2 cm · exclusively formula‐fed preterm or low birth weight infants
1 finding from 1 review
Episodes of gastric residuals3 > 50% of last feed remaining · exclusively formula‐fed preterm or low birth weight infants
1 finding from 1 review
Days until 420 joules per kilogram · exclusively formula‐fed preterm or low birth weight infants
1 finding from 1 review
Necrotising enterocolitis · exclusively formula‐fed preterm or low birth weight infants
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mortality before hospital discharge · exclusively formula‐fed preterm or low birth weight infants
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Invasive infection (any organism) · exclusively formula‐fed preterm or low birth weight infants
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Low birthweight · Women with a multiple pregnancy
Vaginal progesterone showed no clear difference in infant birthweight less than 2500 g compared with no treatment or placebo (moderate certainty).
1 finding from 1 review
Low birthweight · Women with a multiple pregnancy
Intramuscular (IM) progesterone showed no clear difference in infant birthweight less than 2500 g compared with no treatment or placebo (moderate certainty).
1 finding from 1 review